United Therapeutics Corp

-4.20 (-1.85%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)10.49B
Current PE10.65
Forward PE 9.55
2yr Forward PE 9.18
See more stats
Estimates Current Quarter
Revenue$621.93 Million
Adjusted EPS$5.78
See more estimates
10-Day MA$218.65
50-Day MA$221.80
200-Day MA$226.10
See more pivots

United Therapeutics Corp Stock, NASDAQ:UTHR

1000 Spring Street, Silver Spring, Maryland 20910
United States of America
Phone: +1.301.608.9292
Number of Employees: 1168


United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.